Lidocaïne/Prilocaïne Biogaran (Lidocaine, Prilocaine)

Lidocaine, together with prilocaine, blocks voltage‑gated sodium channels in peripheral nerves. This inhibition prevents the generation and propagation of action potentials, thereby stopping pain signals from reaching the brain and producing a temporary loss of sensation at the site of application.

The appropriate amount and frequency of application are determined by the prescribing healthcare professional based on the procedure, patient age, and treatment area. The product is applied as a thin layer to intact skin and covered according to the clinician’s instructions.

Safety data for use in pregnancy and lactation are limited. The prescriber should evaluate the potential benefits against possible risks before recommending the product to pregnant or nursing individuals.

Enquiries can be submitted on the product page at gnhindia.com by specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lidocaine/prilocaine combines two amide‑type anesthetics, offering broader coverage and a slightly longer duration of action compared with single‑agent products such as lidocaine alone. This combination can provide more effective surface anesthesia for procedures that require deeper or more sustained numbness.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain product integrity.

The medication is applied topically to clean, intact skin. A thin layer is spread over the intended area, and the site may be covered with an occlusive dressing if recommended by the clinician. The product should not be injected or used on mucous membranes unless specifically directed.

Serious adverse events, though rare, include systemic toxicity such as central nervous system symptoms (e.g., seizures), cardiovascular effects (arrhythmias, hypotension), allergic contact dermatitis, and methemoglobinemia. Immediate medical attention is required if any of these symptoms develop.

Patients with known hypersensitivity to lidocaine, prilocaine, or other amide‑type local anesthetics should avoid this product. It is also contraindicated on large, broken, or infected skin areas, and caution is advised in neonates, infants, and individuals with severe cardiac or hepatic impairment.